Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Liabilities and Shareholders Equity (2022 - 2025)

Historic Liabilities and Shareholders Equity for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to $5.8 million.

  • Neuraxis' Liabilities and Shareholders Equity rose 40524.97% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.7 million, marking a year-over-year increase of 29473.24%. This contributed to the annual value of $4.8 million for FY2024, which is 83377.64% up from last year.
  • Per Neuraxis' latest filing, its Liabilities and Shareholders Equity stood at $5.8 million for Q3 2025, which was up 40524.97% from $7.1 million recorded in Q2 2025.
  • Neuraxis' Liabilities and Shareholders Equity's 5-year high stood at $7.1 million during Q2 2025, with a 5-year trough of $509498.0 in Q4 2023.
  • Its 4-year average for Liabilities and Shareholders Equity is $2.7 million, with a median of $1.5 million in 2023.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 6558.94% in 2023, then soared by 83377.64% in 2024.
  • Over the past 4 years, Neuraxis' Liabilities and Shareholders Equity (Quarter) stood at $1.5 million in 2022, then tumbled by 65.59% to $509498.0 in 2023, then surged by 833.78% to $4.8 million in 2024, then rose by 21.41% to $5.8 million in 2025.
  • Its last three reported values are $5.8 million in Q3 2025, $7.1 million for Q2 2025, and $3.0 million during Q1 2025.